Dao Viet Hang1,2, Dinh Thi Minh2, Tran Hieu Hoc3, Le Hong Phuoc4, Tran Que Son3, Ngoan Tran Le5,6. 1. Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam. 2. Institute of Gastroenterology and Hepatology, Hanoi, Vietnam. 3. Department of Surgery, Hanoi Medical University, Hanoi, Vietnam. 4. Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam. 5. Institute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam. 6. Department of Public Health, School of Medicine, International University of Health and Welfare, Japan.
Abstract
BACKGROUND: H. pylori infection may play a role in the development of colorectal cancers (CRC). We aimed to examine the association between H. pylori infection and the risk of CRC by anatomical locations. METHODS: We conducted a case-control study on 91 incidence cases of CRC and 224 hospital controls. CRC was determined by histopathological examinations. H. pylori IgG antibody in serum was tested. We collected data on the diet, nutrition, and lifestyle by the validated semi-quantitative food frequency and demographic lifestyle questionnaire. The odds ratio and 95% confidence interval (OR (95%CI) were estimated for CRC and its subgroups. RESULTS: Overall 54.95% of CRC cases and 42.41% of the controls were H. pylori-seropositive, OR (95%CI): 1.56 (0.88, 2.74), p for trend=0.115. Positive dose-response association in quartiles, highest vs lowest, was observed for total CRC, OR (95%CI): 2.14 (1.00, 4.58), p for trend=0.049, for proximal colon, OR (95%CI): 1.52 (0.37, 6.25), p for trend=0.571), and for distal colon and rectum cancers combined, OR (95%CI): 2.38 (1.03, 5.50), p for trend=0.039. CONCLUSIONS: There is a positive association between H. pylori and colorectal cancers, especially distal colon and rectum cancers combined, but additional research is needed to determine the underlying mechanism of chronic H. pylori infection-induced CRC in humans.
BACKGROUND: H. pylori infection may play a role in the development of colorectal cancers (CRC). We aimed to examine the association between H. pylori infection and the risk of CRC by anatomical locations. METHODS: We conducted a case-control study on 91 incidence cases of CRC and 224 hospital controls. CRC was determined by histopathological examinations. H. pylori IgG antibody in serum was tested. We collected data on the diet, nutrition, and lifestyle by the validated semi-quantitative food frequency and demographic lifestyle questionnaire. The odds ratio and 95% confidence interval (OR (95%CI) were estimated for CRC and its subgroups. RESULTS: Overall 54.95% of CRC cases and 42.41% of the controls were H. pylori-seropositive, OR (95%CI): 1.56 (0.88, 2.74), p for trend=0.115. Positive dose-response association in quartiles, highest vs lowest, was observed for total CRC, OR (95%CI): 2.14 (1.00, 4.58), p for trend=0.049, for proximal colon, OR (95%CI): 1.52 (0.37, 6.25), p for trend=0.571), and for distal colon and rectum cancers combined, OR (95%CI): 2.38 (1.03, 5.50), p for trend=0.039. CONCLUSIONS: There is a positive association between H. pylori and colorectal cancers, especially distal colon and rectum cancers combined, but additional research is needed to determine the underlying mechanism of chronic H. pylori infection-induced CRC in humans.
Entities:
Keywords:
Case-control study; H. pylori; colorectal cancer
Authors: Yan Zhang; Michael Hoffmeister; Melanie N Weck; Jenny Chang-Claude; Hermann Brenner Journal: Am J Epidemiol Date: 2012-01-31 Impact factor: 4.897
Authors: Bang V Nguyen; Khanh G Nguyen; Cam D Phung; Odile Kremp; Nicolas Kalach; Christophe Dupont; Josette Raymond; Gwenaëlle Vidal-Trecan Journal: Am J Trop Med Hyg Date: 2006-04 Impact factor: 2.345
Authors: Meira Epplein; Michael Pawlita; Angelika Michel; Richard M Peek; Qiuyin Cai; William J Blot Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-09-17 Impact factor: 4.254
Authors: Tung L Nguyen; Tomohisa Uchida; Yoshiyuki Tsukamoto; Dung T Trinh; Long Ta; Bang H Mai; Song H Le; Ky D Thai; Dung D Ho; Hai H Hoang; Takeshi Matsuhisa; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami; Toshio Fujioka; Yoshio Yamaoka; Masatsugu Moriyama Journal: BMC Gastroenterol Date: 2010-09-30 Impact factor: 3.067
Authors: Annamari Kilkkinen; Harri Rissanen; Timo Klaukka; Eero Pukkala; Markku Heliövaara; Pentti Huovinen; Satu Männistö; Arpo Aromaa; Paul Knekt Journal: Int J Cancer Date: 2008-11-01 Impact factor: 7.396